MedInformatix Shares “State of RIS” Survey Results

Industrywide Survey Says RIS Marketplace Favors Functionality Over Cost; Accessing and Using Data More Challenging than Government Mandates

Los Angeles, CA – (February 15, 2018) RIS innovator MedInformatixannounced today results of a recently concluded survey that examined “The State of RIS” in the radiology industry. The survey, which was launched on the show floor at the 2017 Radiological Association of North America Annual Meeting held in December, looked at perspectives across the radiology landscape, from practices of all sizes and utilizing a wide range of industry RIS solutions including Epic, McKesson, Carestream, Phillips, MedInformatix and other systems.

“This survey provided some very interesting insight into the state of radiology information systems,” said Pat McGonigle, President and CEO of MedInformatix. “We have conducted surveys before, but always from a MedInformatix perspective. With this initiative, we zoomed out and looked at the larger radiology marketplace to gain a broader perspective of the issues, trends and topics now and into the future.”

Heading into what promises to be another unpredictable year in healthcare, McGonigle says it’s his hope that MedInformatix is perceived as an agent of positive change in the rapidly evolving and innovating world of healthcare information technology. “To the extent the results of this survey contribute to that, we are pleased to share its results.”

Key findings of the MedInformatix State of RIS Survey include:

Features and functionality drive selection - 58 percent of respondents ranked RIS features and functionality as the most important factor when selecting a new RIS. Customization was the second leading factor followed closely behind by cost. The brand name of the RIS provider and access to key personnel were distant factors.

Improved workflow is the goal - When it came to examining the output of a RIS, 58 percent of those polled listed improved workflow at their practice as the single biggest benefit they hope to achieve.

Access to data is important - Just over a quarter of respondents, 26 percent, listed access to business and clinical analytics and data as an intended benefit of their RIS, followed by efficiencies in revenue cycle management and improved patient-physician communications.

But how to use that data is a growing challenge - Like healthcare itself, the healthcare information technology sector is in an ongoing state of change, with increasing regulations and mandates imposing their will on a practice’s technology infrastructure. The Quality Payment Program is just one of the latest initiatives to have an impact on a practice’s RIS.

Despite these regulatory changes, some radiology providers see other challenges as more pressing, namely how they are able to leverage the data their practices house in their RIS. Close to 60 percent of those surveyed said the ability to leverage the data they have at their practice as the single biggest challenge they face, compared with just 26 percent of respondents who cited keeping up with industry regulations as their top concern.

According to McGonigle, the survey’s findings of accessing and leveraging data confirms what he hears from his company’s own customers. “We first detected a trend over a year ago suggesting data is both a mission-critical function as well as a mission-critical challenge for radiology providers of all sizes. As a result, our product development teams upgraded our system functionality to enable MedInformatix clients to turn their data into actionable business intelligence. The results have thus far been positive and we will continue to make this a priority moving forward.”

The industrywide survey was conducted in collaboration with Survey Monkey.

About MedInformatix:

MedInformatix, Inc. (www.medinformatix.com) is an innovator in Practice Management (PM) and Electronic Health Records (EHR), and a leading national IT solutions provider of data and workflow solutions to the healthcare industry. Radiology and ambulatory practices from around the country have benefited from their award-winning software solutions.

MedInformatix Version 7.6 is certified to meet 2014 criteria supporting Stage 1 and 2 Meaningful Use requirements under the American Recovery and Reinvestment Act (ARRA), and as a Complete EHR by the Drummond Group. This Complete EHR is 2014 Edition compliant and has been certified by an ONC-ACB in accordance with the applicable certification criteria adopted by the U.S. Secretary of Health and Human Services. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.

MedInformatix, 11/21/2013, MedInformatix v7.6, Criteria Certified: 170.314(a)(1‐15); 170.314(b)(1‐5, 7);170.314(c)(1‐3); 170.314(d)(1‐9); 170.314(e)(1‐3); 170.314(f)(1‐3); 170.314(g)(2‐4), Certification ID Number: 11212013‐1814‐6, Clinical Quality Measures Certified: CMS002v3; CMS022v2; CMS050v2; CMS052v2; CMS056v2; CMS061v3; CMS062v2; CMS064v3; CMS065v3; CMS066v2; CMS068v3; CMS069v2; CMS074v3; CMS075v2; CMS077v2; CMS082v1; CMS090v3; CMS117v2; CMS122v2; CMS123v2; CMS124v2; CMS125v2; CMS126v2; CMS127v2; CMS128v2; CMS129v3; CMS130v2; CMS131v2; CMS132v2; CMS133v2; CMS134v2; CMS135v2; CMS136v3; CMS137v2; CMS138v2; CMS139v2; CMS140v2; CMS141v3; CMS142v2; CMS143v2; CMS144v2; CMS145v2; CMS146v2; CMS147v2; CMS148v2; CMS149v2; CMS153v2; CMS154v2; CMS155v2; CMS156v2; CMS157v2; CMS158v2; CMS159v2; CMS160v2; CMS161v2; CMS163v2; CMS164v2; CMS165v2; CMS166v3; CMS167v2; CMS169v2; CMS177v2; CMS179v2; CMS182v3. Additional software used: Alere Analytics™, Updox Direct 2014, NetTime; MedlinePlus Connect, NewCropRX.

This certified product may require a one-time license and implementation and training fee and ongoing annual maintenance and support. Incremental cost that an eligible provider would incur to implement this certified product in order to meet meaningful use objectives and measures may include a one-time cost to establish interfaces for outbound lab orders, inbound lab results, HIE’s and registries, ongoing monthly support cost on applicable interfaces, ongoing subscription fee for Third Party Software used to meet Meaningful Use (including, but not limited to: Alere Analytics™, Updox Direct 2014, and NewCropRX.